CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO)

15 filings reported holding CERO - CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share as of Q2 2024.
CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.87M shares of 5.17M outstanding shares and own 36.12% of the company stock.
Largest 10 shareholders include ARCH Venture Management, LLC (1.44M shares), Arena Investors LP (199K shares), Avantax Planning Partners, Inc. (80K shares), GEODE CAPITAL MANAGEMENT, LLC (48.1K shares), JANE STREET GROUP, LLC (32K shares), TWO SIGMA INVESTMENTS, LP (18.1K shares), Corient Private Wealth LLC (15K shares), Birchview Capital, LP (13K shares), HRT FINANCIAL LP (11.9K shares), and FNY Investment Advisers, LLC (5.25K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.